chrisvoncsefalvay/vaers-outcomes huggingface dataset:
talked to pt on phone. described arm red from shoulder to mid bicep. has 2 red raised bumps close to each other on bicep. also says she can't move her arm. I recommended being evaluated as soon as possible and to start benadryl. unsure if pt followed through with evaluation
PAIN ON INJECTION SITE, HEADACHE,TIRED,MUSCULAR PAIN, CHILLS, SWELLING ON INJECTION SITE, NAUSIA, FEELING BAD, INCHING ON INJECTION SITE. ONE DAY OF SINTOMES.
pt recvd vax & exp rash on arms & legs; treated w/Medrol Dosepak & periactin; No further details available;
Information has been received from a physician via company representative referring to a 71 year old female patient with osteopenia and drug reactions/allergies to general anesthesia. On 03-MAR-2015 the patient was vaccinated with a dose of ZOSTAVAX, lot # K015308, one single shot. On 23-MAR-2015, the patient developed shingles on her lower left back and abdomen after receiving ZOSTAVAX and she complained of burning and pain. The patient sought medical attention by spoken with the physician. The patient was treated with VALTREX, prednisone and NORCO (dosages, frequencies and manufacturers unknown). There was no lab diagnostics studies performed. The outcome of the event was reported as not resolved. Additional information has been requested.
#1 -- Dealt with heart palpitations & sweating & breathlessness for 2 months after vaccine  #2 -- COVID 19 (breakthrough) -- 5 days in bed, 10 days quarantine -- cough, chills with no fever, muscle aches, CONGESTION, headache, fatigue, thought processing difficulties, no smell & taste
numbness in right hand middle finger; the tip of the finger and under nail turning purple; body aches; chills; feeling sick overall; headache; This is a spontaneous report from a contactable consumer. A 64-year-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Batch/Lot Number: El19269; Expiration Date: unknown), dose 2 via an unspecified route of administration, in Arm Left on 08Feb2021 14:30 as single dose, dose 1 on19Jan2021 09:15 AM in left arm for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included atorvastatin, zinc, ascorbic acid. The patient did not had covid prior or post the vaccination. On 08Feb2021, 20:00 the patient experienced numbness in right hand middle finger, the tip of the finger and under nail turning purple, body aches, chills, feeling sick overall, headache. Treatment for the adverse events was not received. The outcome of the event was recovering.  No follow-up attempts are possible, and no information is required.
This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of COVID-19 (Tested positive for Covid after receiving the COvid-19 vaccine) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.   No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for Covid after receiving the COvid-19 vaccine). At the time of the report, COVID-19 (Tested positive for Covid after receiving the COvid-19 vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was exposed to Covid prior to getting the Covid-19 vaccine. After the vaccination a few days later patient tested positive for Covid.  Treatment information and concomitant product were not provided.
I had a fever 103 evening of 05/13/2021 , chills, headache, and vomiting.
COULDN'T SLEEP LAST NIGHT; TINY HEADACHE; LEFT ARM HURTING; LEFT SHOULDER HURTING; This spontaneous report received from a patient concerned a 43 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1802068 expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 at 14.30 to left deltoid at 14:30 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the patient experienced couldn't sleep last night. On 07-APR-2021, the patient experienced tiny headache. On 07-APR-2021, the patient experienced left arm hurting. On 07-APR-2021, the patient experienced left shoulder hurting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tiny headache, left arm hurting, and left shoulder hurting, and the outcome of couldn't sleep last night was not reported. This report was non-serious.
patient woke up @ 0300 with diarrhea, generalized body aches, headaches and fever. symptoms ongoing by 0920
apx  6  hours after first shot had slight headache ...apx  12 hours after first dose shot had ongoing headache sporadic chills and fatigue Took tylenol and headache resolved chills and malaise was on and off and overall very mild  All side effects were gone within  48 hours
18APR92 t104 R @ 3AM (day p/inject); APAP & cool bath given to reduce temp;
Shingles; This initial spontaneous report was received on 16-OCT-2019, from a lawyer regarding a case in litigation and refers to a male patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On an unspecified date in 2013, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (the dosage regimen information was not reported) as prescribed and/or administered by a healthcare provider for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to the patient's vaccination, he was treated by a physician for shingles. As a direct and proximate result of patient's vaccination with zoster vaccine live (ZOSTAVAX), he had and would continue suffering injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs included care for hospitalizations, physical care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life, quality of life, increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions. At the time of the report, the outcome of shingles was not recovered. The causality assessment was related.
Rash appeared on arm. Not raised or blistery or itchy. Just looked like someone slapped her. Advised to put hydrocortisone cream on affected area and to call if it got worse.
Swelling throat; Tightening of throat; Shortness of breath, difficulty breathing; Swelling of eyes; Swelling face, cheeks; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PHARYNGEAL SWELLING (Swelling throat), THROAT TIGHTNESS (Tightening of throat), DYSPNOEA (Shortness of breath, difficulty breathing), EYE SWELLING (Swelling of eyes) and SWELLING FACE (Swelling face, cheeks) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Acid reflux (esophageal), Constipation and Stress. Concurrent medical conditions included Food allergy (Allergy to string beans), Dust allergy and Penicillin allergy. Concomitant products included FAMOTIDINE for Acid reflux (esophageal), LINACLOTIDE (LINZESS) for Constipation, POTASSIUM CITRATE and CHLORTHALIDONE for Kidney stone prevention, BUPROPION and DULOXETINE for Stress, VITAMIN D3, FISH OIL, ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]) and MAGNESIUM for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PHARYNGEAL SWELLING (Swelling throat), THROAT TIGHTNESS (Tightening of throat), DYSPNOEA (Shortness of breath, difficulty breathing), EYE SWELLING (Swelling of eyes), SWELLING FACE (Swelling face, cheeks) and HEADACHE (Headache). On 03-Mar-2021, PHARYNGEAL SWELLING (Swelling throat), THROAT TIGHTNESS (Tightening of throat), DYSPNOEA (Shortness of breath, difficulty breathing), EYE SWELLING (Swelling of eyes), SWELLING FACE (Swelling face, cheeks) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Consumer reported cellulitis began in late Mar-2021. Treatment for cellulitis included oral and intravenous antibiotics.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-060919 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Initial report received on 10 September 2009 from a consumer. A 3 year old female patient finished her fourth dose of DAPTACEL (lot number, route, and site of administration was not known) on an unspecified date. The patient had pertussis confirmed by a nasal swab. No further information was provided. List of Documents held by sender: none.
Wheezing, difficulty breathing, hoarseness, dizziness. they started appearing about 7:30-8pm during dinner. it was about 3 1/2 - 4 hours later. Went to Dr at earliest appointment which was at 11:40am the next day.
Had a Stroke on 5/14/21 confirmed with MRI.  In ICU for 4 days. Inpaired speech, and left side arm, leg.
My adverse event started on 01/10/2023 in the morning at 8:00AM. I had painful blisters on my nose. It was red and swollen. I called my doctor the next day on 01/11/2023  and scheduled an appointment. The nurse did a viral swab and a bacterial swab. I was positive with the viral swab for herpes. I was also positive for bacterial swab for Bacilli. The nurse prescribe me with an antiviral medication called valacyclovir for 4 days. I also went to a different doctor to discuss my results on 01/14/2023. He prescribe me with antibiotics clindamycin for 10 days and mupirocin ointment.
Immediately upon the insertion of the needle, I had horrible shooting pain down my arm, across my shoulder and into neck and jaw.  Extreme soreness and inabiity to move arm in almost any direction has continued since and only mildly abated.  I am awakened constantly through the night and can not perform simple household chores.  Dressing is difficult.  Have had xray and sonogram but no answer to what is going on.
Patient presented to the emergency department on 6/15/2021 with weight gain, peripheral edema, and worsening dyspnea. Patient has a history of CHF. Upon admission screening, he was found to be COVID-19 positive. He was treated for COVID-19 infection as well as CHF exacerbation. He is currently admitted at time of writing.
My face (cheeks and jaw area) swelled slightly and my tongue and back of my throat became red, swollen, and patchy for about 4 days after the shot. I also lightly bled on my tongue and in the back of my throat.  After my second Moderna vaccine on 5/11/2021, I also had some tongue and throat redness but not as badly as after this 3rd dose.  All of these reactions started the next morning after I woke up.
SHINGLES: on L3/L4 - left side of lower back along belt line, wraps around hip to cross thigh & continues down her inner side of knee & calf.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable consumer (patient), then received from a Pfizer-sponsored program (Pfizer First Connect). This consumer reported similar events for two patients. This is the first of two reports. A 72 years old female patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL0142) on 05Jan2021, for COVID-19 immunization. Medical history and concomitant medications were none. On 08Jan2021 the patient was tested positive for COVID 19. Events outcome was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021026991 same reporter/drug/AE, different patient
Patient was observed by NP having mild seizure activity immedetly after receving the flu vaccine.  Activity lasting only seconds.  Patient was lowered to floor and assessed by attending NP
Patient was given the vaccine during schedule clinic at long term care facility and next day she has redness and soreness in her arm. Patient's daughter in law as complained to pharmacy about adverse reaction and insisted that we file it. I only have information about redness and soreness to injection site which is common reaction to vaccine.
Fine papular rash on both deltoids 9/1/11. Swelling of deltoids 9/6/11; Fever, fatigue cervical lymphadenitis R/L; parotid/submental R > L 9/2/11  - 9/6/11 Treated with amoxicillin and AUGMENTIN.
Urticaria, rash. It was reported that a female pt received vax on 09/02/99. Reportedly sometime after the vax, the pt experienced hives and rash over entire body.
Pt recvd 3 doses of Engerix-B, 3rd dose given 14JUN90 & it was determined that pt did not convert to a protective surface antibody level;
Left arm swelled twice the size for 2 days.  Pt given Cephalexin sus 125/5mL 150mg per mouth three times a day.
Mother called the office asking if his arm should still be hurting from the vaccine. Per mom the right deltoid is swollen the size of a fist, red and hand tingling. Told to use cool compresses and Tylenol and to be seen if no improvement. Seen on 10/30/2015 and the area is still red, warm to the touch and painful. The area is swollen the size of a fist with residule marks from the day before. He is referred to his allergist for further direction.
Patient called the pharmacy on 10/15/21, 2 days post vaccination, to report rash on shoulder area above injection site. Reports it is not red and can not be seen unless looking at it the "right way". Not painful, swollen or itchy. Just bumps about size if his hand.
After taking the 2nd dose, I felt like I couldn't fully bend my arm. It hurt really badly. Its hard for me to pick up my child. Its also difficult for me to exercise or surf. I can't do the normal activities that I used to do.   I thought the pain was going to go away, but it hasn't. I went to the doctor and took X-Rays. I did some physical therapy for my arm, but that didn't help much. My doctor could not figure out the root cause of the pain, but all of this started after taking my 2nd shot. I was given Diclofenac Sodium, but that did not help much either.
After 2nd vaccine i experienced side effects starting 24 hrs. After injection.  Expierenced fever of 101 f. With chills and body aches.  Extremely fatigued.  Lasted about 6-7 hours before fever went away along with all other symptons.  I took ibuprofen for the fever and aches.  Spent several hours in bed!
Right arm red and warm to touch. Slightly swollen. Gave vaccines on 11/3/04. Swelling started on 11/4/04. Provider gave Augmentin 400/5, Zyrtec and was told to elevate.
Vertigo; Can't walk; Could not hear clear with left ear; Cold sore; Body aches; Vomiting; Chills; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (Could not hear clear with left ear), VERTIGO (Vertigo), GAIT INABILITY (Can't walk), ORAL HERPES (Cold sore) and PAIN (Body aches) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Vertigo (several years ago). Concurrent medical conditions included Hearing loss (Right ear due to ear condition) and Ear disorder NOS. Concomitant products included LISINOPRIL for an unknown indication.   On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced ORAL HERPES (Cold sore), PAIN (Body aches), VOMITING (Vomiting), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). On 19-Feb-2021, the patient experienced HYPOACUSIS (Could not hear clear with left ear). On 23-Feb-2021, the patient experienced VERTIGO (Vertigo) and GAIT INABILITY (Can't walk). The patient was treated with DIPHENHYDRAMINE ongoing since an unknown date at a dose of 1 dosage form and PARACETAMOL ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, HYPOACUSIS (Could not hear clear with left ear), ORAL HERPES (Cold sore), PAIN (Body aches), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown and VERTIGO (Vertigo), GAIT INABILITY (Can't walk), VOMITING (Vomiting) and PYREXIA (Fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: high (High) 100.2 F.         Action taken with mRNA-1273 in response to the events was not applicable; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Light headed, felt like heart racing, dizzy, Rested for 20-30 minutes. Resolved.
not feeling so good today; little tired/ extremely tired; BLURRED VISION/ SHE CAN'T SEE RIGHT; RAPID HEART RATE/feel like HYPERTENSION; DIZZINESS; MUSCLE ACHES; WAS UP ALL NIGHT; This case was reported by a nurse and described the occurrence of feeling unwell in a 52-year-old female patient who received Flu unspecified (Flu vaccine) for prophylaxis.   Co-suspect products included niraparib (Zejula) capsule (batch number 2057808, expiry date 30th June 2024) for ovarian cancer and COVID-19 VACCINE (COVID VACCINE) for prophylaxis.   The patient's past medical history included asthma and hysterectomy. Concurrent medical conditions included ovarian cancer.   On 15th September 2022, the patient received Flu vaccine. On 19th September 2022, the patient started Zejula (oral) 100 mg twice daily (200 mg daily). On 15th September 2022, the patient received COVID VACCINE. On 19th September 2022, 4 days after receiving Flu vaccine and less than a day after starting Zejula, the patient experienced feeling unwell, tiredness, blurred vision, heart rate increased, dizziness, muscle pain and sleep disturbance. The action taken with Zejula was unknown. On an unknown date, the outcome of the feeling unwell, tiredness, blurred vision, heart rate increased, dizziness, muscle pain and sleep disturbance were not recovered/not resolved.   It was unknown if the reporter considered the feeling unwell, tiredness, blurred vision, heart rate increased, dizziness, muscle pain and sleep disturbance to be related to Flu vaccine and Zejula.     Additional Information: GSK Receipt Date: 23-SEP-2022 Reporter's Comments:The patient stated that she was not feeling so good today. The patient got her Covid and Flu vaccine on Thursday. The patient was little tired to be honest. The patient reported that she was extremely tired, she was brought to tears when she was talking about how tired she was. The patient getting a little blurred vision stating that she could not saw right. The patient experienced little rapid heart rate, dizziness and muscle aches. The patient was up all night and she could felt liked hypertension, although she had not checked her blood pressure. The patient need to take her blood pressure . Medical physician was not aware. The patient did want to speak to pharmacist about stopping the medication. The physician was not aware. The patient had not stopped Zejula. Zejula label instructions: took 2 capsules 200 mg total daily as directed on days 1 thought 28 of your chemotherapy cycles It was unknown if the reporter considered the feeling unwell, tiredness, blurred vision, heart rate increased, dizziness, muscle pain, sleep disturbance and hypertension to be related to Covid vaccine.
Triage. Pt called regarding pneumonia shot that was given to her last visit 8/28 and she stated that its been swollen and very painful and red. On Saturday she felt like she had a mild fever.
6 months post first dose and has not received the second dose; Shortness of breath after first shot; Side Effects after first shot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Jul-2021 and was forwarded to Moderna on 29-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath after first shot), VACCINATION COMPLICATION (Side Effects after first shot) and PRODUCT DOSE OMISSION ISSUE (6 months post first dose and has not received the second dose) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced DYSPNOEA (Shortness of breath after first shot) and VACCINATION COMPLICATION (Side Effects after first shot). On 29-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (6 months post first dose and has not received the second dose). In January 2021, DYSPNOEA (Shortness of breath after first shot) and VACCINATION COMPLICATION (Side Effects after first shot) had resolved. On 29-Jul-2021, PRODUCT DOSE OMISSION ISSUE (6 months post first dose and has not received the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment information was reported.   Reporter did not allow further contact
Patient experienced fever, body aches, and nausea followed by severe vomiting that laster for 2 hours.
Leg started to swell; Burning sensation in the feet; Pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Leg started to swell), BURNING SENSATION (Burning sensation in the feet) and PAIN IN EXTREMITY (Pain) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Sep-2021, the patient experienced PERIPHERAL SWELLING (Leg started to swell), BURNING SENSATION (Burning sensation in the feet) and PAIN IN EXTREMITY (Pain). At the time of the report, PERIPHERAL SWELLING (Leg started to swell), BURNING SENSATION (Burning sensation in the feet) and PAIN IN EXTREMITY (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was under no medication. He was not under any prescription at the time of the symptoms started and never experienced this symptom before.
She had swelling and tenderness the next day, 10 days later she developed a cellulitis left deltoid.